Daily briefing: How synthetic 'mirror life' bacteria could infect the world
Elon Musk's influence on US science could lead to budget cuts that may hinder innovation.
New CRISPR treatment shows long-term potential but raises accessibility concerns.
The creation of synthetic organisms with reversed handedness poses ecological risks.
Combining AI and Crispr Will Be Transformational
AI and machine learning are set to enhance Crispr genome editing's impact across multiple fields by 2025.
Daily briefing: Big tomatoes get sweeter thanks to CRISPR editing
Genetic modifications can significantly enhance the sweetness of tomatoes without altering their size.
Mobile phone data can improve the mapping and understanding of the ionosphere and navigation systems.
Scientists Made a CRISPR Breakthrough for Autoimmune Diseases
Promising CRISPR treatments using donor cells may revolutionize the management of autoimmune conditions for millions of Americans.
Other Barks & Bites for Friday, September 27: FTC Appeals Ruling on Noncompete Ban; the TTAB Cancels Four DC and Marvel SUPER HERO Trademarks; OpenAI Agrees to Share Training Data with Authors Suing for Copyright Infringement
The TTAB has canceled superhero trademarks from Marvel and DC after legal challenges, impacting their intellectual property ownership.
Nobel winners seek to preemptively cancel their CRISPR patent to avoid its invalidation.
A Rose Without Thorns? How Gene Editing Is Giving Plants A Glow-Up
The discovery of a gene controlling prickliness can lead to the development of smooth, prickle-free plants without compromising fruit and flower quality.
Crispr-Enhanced Viruses Are Being Deployed Against UTIs
Locus's phage therapy effectively targets and degrades E. coli bacteria, showing promising results in treating urinary tract infections (UTIs).
Leadership essentials: "Inspire, motivate, and cultivate"
Scribe Therapeutics, led by CEO Benjamin Oakes, aims to revolutionize genetic medicine through innovative genome editing technology.
Rat Neurons Repair Mouse Brains That Lack a Sense of Smell
Chimeras in the form of mice with rat neurons exhibit brain adaptability for potential disease study and tissue transplantation.
Generative A.I. Arrives in the Gene Editing World of CRISPR
Generative A.I. technology can create blueprints for microscopic biological mechanisms to edit DNA for battling illnesses with precision and speed.